Abstract
Epilepsy is a serious brain condition characterized by recurring seizures. It affects millions of people across the globe. Much advancement in the past has improved the understanding of the underlying pathophysiology and risk factors for epilepsy. These advances have led to the development of both new terminologies and classification as well as treatment strategies for the disease. Despite the fact that various antiepileptic drugs have been developed in past decades, major part of affected population remains either resistant or refractory to the currently available therapy. Also, none of these anticonvulsant agents are devoid of serious side effect. Therefore, constant efforts are being made to develop antiepileptic drugs with improved efficacy and better pharmacokinetic and safety profile. The new structural classes which are being developed broadly amides, amino acids and a number of heterocyclic agents like oxadiazoles, benzimidazoles, benzothazoles, pyrazoles, indoles and benzothaizoles etc. These new compounds have potential for identification of novel targets and drug development. This review makes a note of these issues and describes recent developments in antiepileptic drug discovery.
Keywords: Antiepileptic drugs, epilepsy, heterocycles, seizure, tonic-clonic.
Mini-Reviews in Medicinal Chemistry
Title:Past, Present and Future of Antiepileptic Drug Therapy - Finding a Place for Heterocyclics
Volume: 15 Issue: 12
Author(s): Ruhi Ali, Mohammad Ahmed Khan and Nadeem Siddiqui
Affiliation:
Keywords: Antiepileptic drugs, epilepsy, heterocycles, seizure, tonic-clonic.
Abstract: Epilepsy is a serious brain condition characterized by recurring seizures. It affects millions of people across the globe. Much advancement in the past has improved the understanding of the underlying pathophysiology and risk factors for epilepsy. These advances have led to the development of both new terminologies and classification as well as treatment strategies for the disease. Despite the fact that various antiepileptic drugs have been developed in past decades, major part of affected population remains either resistant or refractory to the currently available therapy. Also, none of these anticonvulsant agents are devoid of serious side effect. Therefore, constant efforts are being made to develop antiepileptic drugs with improved efficacy and better pharmacokinetic and safety profile. The new structural classes which are being developed broadly amides, amino acids and a number of heterocyclic agents like oxadiazoles, benzimidazoles, benzothazoles, pyrazoles, indoles and benzothaizoles etc. These new compounds have potential for identification of novel targets and drug development. This review makes a note of these issues and describes recent developments in antiepileptic drug discovery.
Export Options
About this article
Cite this article as:
Ali Ruhi, Khan Ahmed Mohammad and Siddiqui Nadeem, Past, Present and Future of Antiepileptic Drug Therapy - Finding a Place for Heterocyclics, Mini-Reviews in Medicinal Chemistry 2015; 15 (12) . https://dx.doi.org/10.2174/138955751512150731113549
DOI https://dx.doi.org/10.2174/138955751512150731113549 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design Recent Advances in Oral Pulsatile Drug Delivery
Recent Patents on Drug Delivery & Formulation Molecular Cytogenetics of Autism
Current Genomics Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations
Current Neurovascular Research Acne in the Adult
Mini-Reviews in Medicinal Chemistry Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Current Drug Metabolism Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches
Current Pharmaceutical Design Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases
CNS & Neurological Disorders - Drug Targets Next Generation Sequencing in the Management of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Literature Review
Recent Patents on Anti-Cancer Drug Discovery Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets CT-negative Subarachnoid Hemorrhage Caused by Telangiectasia: A Case Report
Current Medical Imaging Therapeutic Benefits of <i>Piper nigrum</i>: A Review
Current Bioactive Compounds GABAB Receptors-Associated Proteins: Potential Drug Targets in Neurological Disorders?
Current Drug Targets Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction
Current Drug Targets Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Antipsychotic and Antiepileptic Drugs in Bipolar Disorder: The Importance of Therapeutic Drug Monitoring
Current Medicinal Chemistry Development of 1, 3 Benzothiazol-2-yl Hydrazine Derivatives Containing Semicarbazone and Thioamide Pharmacophore as Anticonvulsants
Letters in Drug Design & Discovery Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy
Current Pharmaceutical Biotechnology